We originally posted the results from the ICT-107 Glioblastoma (GBM) Clinical Trial back in September 29, 2011 and marked it as a potential game changer in treatment of brain tumors. In shor… Read More
Toca 511 and Toca FC, developed by Tocagen, is a combination treatment currently being investigated in phase I/II trials for recurrent high grade glioma including the notoriously difficult t… Read More
An investor in NYSEMKT:IMUC shares filed a lawsuit over alleged violations of Federal Securities Laws by ImmunoCellular Therapeutics.
Investors who purchased shares of ImmunoCellular Therape… Read More
Cryoport, Inc. (NASDAQ: CYRX) has developed one of the most comprehensive solution platforms available today in the life sciences-focused cryogenic logistics space, with a suite of proprieta… Read More